title: Physicochemical characterization of a minor mucin component from cystic fibrosis tracheobronchial secretions.
abstract: A minor mucin glycoprotein component (HTM-2) was purified from the tracheobronchial secretions of two cystic fibrosis patients using a protocol established in our laboratory. The secretions were solubilized in 0.1 M Tris-HCl buffer (pH 7.5) containing 0.22 M potassium thiocyanate and fractionated on a Bio-Gel A-5m column, followed by digestion with DNAase, rechromatography on the same column and chromatography on hydroxyapatite which resolved the major mucin (HTM-1) from the minor mucin component (HTM-2). The mucin component HTM-2 was further purified using Superose 6 chromatography. SDS-composite gel (2% polyacrylamide + 0.5% agarose) and 6% polyacrylamide gel electrophoresis showed that the purified HTM-2 was totally free of low-molecular-weight contaminants. Equilibrium density sedimentation centrifugation of purified HTM-2 using CsCl gradients also showed the absence of proteoglycans and other low-molecular-weight proteins. Comparison of carbohydrate and amino acid compositions of the two mucin components indicated that HTM-2 was quite different from the major mucin, HTM-1, reported earlier from our laboratory (Biochemistry, 24, 7334, 1985). This suggested that HTM-2 has a different polypeptide core and is perhaps a different gene product. The effects of 6 M guanidine-HCl and different concentrations of NaCl on the molecular size of HTM-2 and its ability to form aggregates was also investigated using the technique of static light scattering. In buffer containing 6 M guanidine-HCl, HTM-2 had a weight-average molecular weight of approximately 4.5 x 10(6). However, in the presence of buffer containing 0.03, 0.10 or 0.15 M NaCl, the molecular weight of HTM-2 was estimated to be approximately 11 x 10(6). These data suggest aggregation of HTM-2 in the presence of a range of NaCl concentrations. In contrast to HTM-1, which is a more anionic glycoprotein, the apparent molecular size of HTM-2 did not decrease at the higher NaCl concentration.
authors.affiliation: College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City 73190.
authors.forename: N V
authors.initials: NV
authors.lastname: Padhye
authors.forename: B
authors.initials: B
authors.lastname: Naziruddin
authors.forename: V C
authors.initials: VC
authors.lastname: Desai
authors.forename: S
authors.initials: S
authors.lastname: Reyes de la Rocha
authors.forename: G P
authors.initials: GP
authors.lastname: Sachdev
mesh_terms: D000596:Amino Acids / Q000032:analysis; D001980:Bronchi / Q000737:chemistry*; D003550:Cystic Fibrosis / Q000378:metabolism*; D006801:Humans; D008970:Molecular Weight; D009077:Mucins / Q000032:analysis*; D012965:Sodium Chloride / Q000494:pharmacology; D014132:Trachea / Q000737:chemistry*
chemical_list: D000596:Amino Acids; D009077:Mucins; D012965:Sodium Chloride